Pharma To Market look forward to catching up with our colleagues at ARCS ASC in Sydney

Pharma To Market look forward to catching up with our colleagues at ARCS ASC in Sydney

We are pleased to bring their six members of our team to the annual ARCS Annual Scientific Conference in Sydney this month. Joelle Chia, Pharma To Market’s Director of their South-East Asian operations will be speaking about regulatory affairs requirements in ASEAN and Daria Wain, Pharma To Market’s Regulatory Publishing Specialist will be speaking about tips to streamline your eSubmission processes. Congratulations to our colleagues at ARCS for pulling together an excellent program. We look forward to catching up with all of our colleagues from across Australia at what promises to be a fantastic conference.


Join us at our first Asia regulatory & pharmacovigilance workshop

Pharma To Market looks forward to hosting you at our first-ever Pharmaceutical Regulatory Affairs & Pharmacovigilance Asia Workshop, happening on the 26th October 2018 in Singapore. This workshop is co-organised together with the Pharmaceutical Society of Singapore.

Do join us for a full-day workshop specially curated to provide participants in the pharmaceutical industry with key regulatory and pharmacovigilance knowledge and actionable insights. Our goal is to bring together industry experts to give talks that are strategy- or implementation-focused so that participants can bring back ideas to help them navigate the complex and ever-changing regulations in the region. The event also aims to provide a networking avenue for regulatory and pharmacovigilance professionals in the region to exchange approaches to current challenges.

Guest speakers from MSD, Novartis, Roche and Sanofi, as well as trainers from Pharma To Market’s Australian office will discuss these topics in the workshop:
• Innovative approaches to deliver regulatory process optimisation in pharma companies
• Overview of regulatory CMC requirements for pharmaceuticals
• Strategic pharmacovigilance literature surveillance Asian hub
• Key risk minimization regulations and their impact on countries in the region
• Fundamentals on pharmacovigilance inspection readiness in Asia
• Lifecycle management – from manufacturing shop-floor to the registered dossier


RAPS Regulatory Convergence

Pharma To Market are pleased to be exhibiting at and attending the RAPS Regulatory Convergence 2016 on 17-20 September 2016 in California, USA.

We are looking forward to meeting our fellow delegates from the USA and around the globe to explore how Pharma To Market can assist companies looking to enter the Australian and other emerging markets.

The congress is a great opportunity to learn more about global healthcare regulations and exchange ideas with key industry leaders.

If you would like to meet with us at the congress to learn how Pharma To Market can help shape your success story, contact